𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chemotherapy versus chemotherapy plus hormonotherapy in postmenopausal advanced breast cancer patients a randomized trial

✍ Scribed by Pablo Viladiu; Maria Carmen Alonso; Antonio Avella; Miguel Beltrán; Juan Borrás; Belen Ojeda; F. Xavier Bosch


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
586 KB
Volume
56
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Phase 2 randomized trial of primary endo
✍ Vladimir F. Semiglazov; Vladislav V. Semiglazov; Garik A. Dashyan; Elena K. Zilt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

## Abstract ## BACKGROUND. Few studies have compared primary neoadjuvant endocrine therapy with neoadjuvant chemotherapy in breast cancer patients. The need for preoperative chemotherapy with doxorubicin or taxanes may be reduced in postmenopausal patients with estrogen receptor (ER)‐positive and/